|
|
|
Insider
Information: |
Love Richard L |
Relationship: |
Director |
City: |
San Antonio |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
122,528 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$670,141 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
122,528 |
|
|
Total
Value |
$670,141 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PAREXEL International |
PRXL |
Director |
2017-09-29 |
0 |
2003-10-24 |
0 |
Premium* |
|
Imarx Therapeutics Inc |
SEGI |
Director |
2008-05-30 |
48,810 |
2007-07-26 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
Director |
2017-09-29 |
73,718 |
2007-09-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,093) |
235,417 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2015-12-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,320) |
472,129 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2017-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(88,302) |
0 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2007-09-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
490,996 |
|
- |
|
PRXL |
PAREXEL International |
Director |
|
2010-08-27 |
4 |
OE |
$4.68 |
$28,830 |
D/D |
5,000 |
85,207 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-02-08 |
4 |
OE |
$7.11 |
$49,770 |
D/D |
7,000 |
94,443 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-02-18 |
4 |
OE |
$6.55 |
$42,850 |
D/D |
6,352 |
95,822 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-02-22 |
4 |
OE |
$6.55 |
$11,110 |
D/D |
1,648 |
91,118 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-08-15 |
4 |
OE |
$8.49 |
$4,245 |
D/D |
500 |
91,618 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-08-31 |
4 |
OE |
$8.49 |
$29,715 |
D/D |
3,500 |
95,118 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-11-21 |
4 |
OE |
$9.15 |
$4,575 |
D/D |
500 |
100,530 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-12-01 |
4 |
OE |
$9.15 |
$22,875 |
D/D |
2,500 |
103,030 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-02-06 |
4 |
OE |
$8.60 |
$352,890 |
D/D |
35,000 |
135,530 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
535,824 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2017-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,736 |
88,318 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-08-12 |
4 |
S |
$1.64 |
$114,800 |
D/D |
(70,000) |
547,405 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2010-08-27 |
4 |
S |
$21.00 |
$105,000 |
D/D |
(5,000) |
80,207 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-02-08 |
4 |
S |
$21.08 |
$104,831 |
D/D |
(4,973) |
89,470 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-02-18 |
4 |
S |
$23.00 |
$146,096 |
D/D |
(6,352) |
89,470 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2011-12-01 |
4 |
S |
$19.92 |
$49,800 |
D/D |
(2,500) |
100,530 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-11-02 |
4 |
S |
$30.16 |
$60,320 |
D/D |
(2,000) |
103,741 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2013-05-20 |
4 |
S |
$46.65 |
$373,200 |
D/D |
(8,000) |
95,741 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-05-24 |
4 |
S |
$1.21 |
$27,853 |
D/D |
(23,000) |
322,308 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2013-08-28 |
4 |
S |
$47.04 |
$235,200 |
D/D |
(5,000) |
90,741 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-12-17 |
4 |
S |
$1.71 |
$10,266 |
D/D |
(6,000) |
403,265 |
0 |
- |
|
82 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|